206 related articles for article (PubMed ID: 21241520)
1. Airway inflammation and mannitol challenge test in COPD.
de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ
Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520
[TBL] [Abstract][Full Text] [Related]
2. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
[TBL] [Abstract][Full Text] [Related]
3. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
4. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
[TBL] [Abstract][Full Text] [Related]
6. Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsiveness.
Singapuri A; McKenna S; Brightling CE; Bradding P
Respirology; 2010 Apr; 15(3):510-5. PubMed ID: 20210888
[TBL] [Abstract][Full Text] [Related]
7. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
8. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.
Obase Y; Shimoda T; Mitsuta K; Matsuo N; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):304-10. PubMed ID: 11289329
[TBL] [Abstract][Full Text] [Related]
9. Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma.
Wood LG; Powell H; Gibson PG
Clin Exp Allergy; 2010 Feb; 40(2):232-41. PubMed ID: 19878195
[TBL] [Abstract][Full Text] [Related]
10. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD.
Chou KT; Su KC; Huang SF; Hsiao YH; Tseng CM; Su VY; Hung SC; Perng DW
Lung; 2014 Aug; 192(4):499-504. PubMed ID: 24816967
[TBL] [Abstract][Full Text] [Related]
11. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
[TBL] [Abstract][Full Text] [Related]
12. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
[TBL] [Abstract][Full Text] [Related]
13. Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients.
Alvarez MJ; Olaguibel JM; Garcia BE; Tabar AI; Urbiola E
Allergy; 2000 Jun; 55(6):531-9. PubMed ID: 10858983
[TBL] [Abstract][Full Text] [Related]
14. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
Tashkin DP; Wechsler ME
Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
16. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
[TBL] [Abstract][Full Text] [Related]
17. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
19. Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.
Scherr A; Schafroth Török S; Jochmann A; Miedinger D; Maier S; Taegtmeyer AB; Chhajed PN; Tamm M; Leuppi JD
Chest; 2012 Oct; 142(4):919-926. PubMed ID: 22459771
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice.
Dima E; Rovina N; Gerassimou C; Roussos C; Gratziou C
Int J Chron Obstruct Pulmon Dis; 2010 Sep; 5():287-96. PubMed ID: 20856828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
